Literature DB >> 14682470

Cortisol metabolism and visceral obesity: role of 11beta-hydroxysteroid dehydrogenase type I enzyme and reduced co-factor NADPH.

Anil K Agarwal1.   

Abstract

Several factors including genetic and environmental play a role in the development of obesity and the metabolic syndrome. The transgenic mouse overexpressing 11beta-hydroxysteroid dehydrogenase (11beta-HSD) develops visceral obesity. However, it remains unclear how a ubiquitously expressed 11beta-HSD1 enzyme affects adipose tissue so much that it would lead to obesity. In this commentary we explore the possibility that increased intracellular availability of reduced co-factor, NADPH, could exacerbate the enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14682470     DOI: 10.1081/erc-120026947

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  3 in total

Review 1.  Reduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe?

Authors:  Nirmala Koju; Zheng-Hong Qin; Rui Sheng
Journal:  Acta Pharmacol Sin       Date:  2022-01-11       Impact factor: 7.169

2.  Do the interactions between glucocorticoids and sex hormones regulate the development of the metabolic syndrome?

Authors:  Marià Alemany
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-27       Impact factor: 5.555

3.  Immortalization of Porcine 11β-Hydroxysteroid Dehydrogenase Type 1-Transgenic Liver Cells Using SV40 Large T Antigen.

Authors:  Hee Young Kang; Young-Kwon Choi; Yeon Ik Jeong; Kyung-Chul Choi; Sang-Hwan Hyun; Woo-Suk Hwang; Eui-Bae Jeung
Journal:  Int J Mol Sci       Date:  2017-12-05       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.